SIC 8731 – Commercial Physical and Biological Research
| Valuation | |
|---|---|
| Market Cap ($M) | 26,071.86 |
| Enterprise Value ($M) | 29,175.27 |
| Book Value ($M) | 9,432.65 |
| Book Value / Share | 114.08 |
| Price / Book | 2.76 |
| NCAV ($M) | -4,060.65 |
| NCAV / Share | -49.11 |
| Price / NCAV | -6.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.21 |
| Current Ratio | 1.21 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3,554.95 |
| Assets | 17,048.25 |
| Liabilities | 7,615.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 8,120.18 |
| Operating Income | 1,045.72 |
| Net Income | 612.34 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 1,161.03 |
| Cash from Investing | -226.65 |
| Cash from Financing | -844.04 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Massachusetts Financial Services Co /ma/ | 6.70 | -31.86 | |
| 13G/A | Wcm Investment Management, Llc | 8.30 | 16.73 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 113,591 | 441,422 | 25.73 | |
| 112,073 | 567,325 | 19.75 | |
| 118,925 | 215,011 | 55.31 | |
| 57,839 | 138,949 | 41.63 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABSI – Absci Corporation | INCY – Incyte Corporation |
| MEDP – Medpace Holdings, Inc. | MXCT – MaxCyte, Inc. |
| NRC – National Research Corporation |
Financial data and stock pages provided by
Fintel.io